Snu Rdb Foundation

Seoul National University

Ajou University Industry-academic Cooperation Foundation

Innotherapy Inc.

Cybermed, Inc.

Sun Ha Paek

Yong Hoon Lim

Hyung Woo Park

Hyun Jae Kang

Cheol Young Kim

Moon Sue Lee

Hae Shin Lee

Seong Woo Ryu

Hye Young Shin

Mi Young Koh

Hyo Eun Moon

Bong Hee Lee

Se Ho Shin

Kyung Hee Byun

Ki Young Lee

Eun Ju Choi

Provided are an implantable medical device control system and a control method therefor, the system comprising: an implantable medical device implanted into the body so as to stimulate a specific area in the body; a management terminal for controlling the driving of the implantable medical device by communicating with the implantable medical device through a wireless communication method; and a management server connected with the management terminal so as to be capable of communicating therewith, assigning priority to each parameter included in patient condition information and storing and managing same, and providing the stored information, and thus, since priority is assigned to each parameter included in patient condition information and stimulation applied to a specific part in the body is adjusted according to the assigned priority, the entire parameter can be controlled such that a patient condition is maintained in a stabilized state by satisfying a preset reference value.

Implantable medical device control system and control method therefor

Disclosed is a carbon material for a neurostimulation electrode. The carbon material is composed of a carbon fiber. The carbon fiber has a thickness of 1 to 1000 &#x3bc;m, a linear density of 0.01 to 5.00 g/cm, and an aspect ratio of 100 to 1,000,000. Particularly, the carbon fiber material can be obtained by dry spinning carbon nanotubes, followed by liquid-based densification. The carbon material can be used in the fields of deep brain stimulation, spinal cord stimulation, etc. Also disclosed are an electrode assembly and a neurostimulation device, each including the carbon material.

Bio-implantable electrode assembly

The present invention relates to a method for diagnosing glioma by comparing the protein location of an individual to be diagnosed with the normal control nerve cells. More particularly, the present invention relates to a method for diagnosing glioma including determining that an individual has glioma when the expression level of GFR&#x3b1;4 in the endoplasmic reticulum is higher than that in the plasma membrane, and a method for screening a therapeutic agent for glioma. In the diagnostic method of the present invention, the protein expression levels in particular subcellular locations are compared, thereby accurately diagnosing glioma, diagnosing progression of glioma, and predicting prognosis after glioma surgery.

Method for diagnosing glioma and screening for the therapeutics of glioma through identifying protein relocation

The present invention relates to a composition for diagnosing a Parkinson's disease comprising mesenchymal stromal cells derived from adipose tissue, a method of providing information for diagnosing Parkinson's disease and/or the extent of the disease progression, a biomarker for diagnosing a Parkinson's disease, a method of screening a drug candidate treating Parkinson's disease where the drug candidate is a target of the biomarker, and an immortalized mesenchymal stromal cell from adipose tissue.

Immortalized mesenchymal stromal cell from adipose tissue

The present invention relates to a method of determining the position of a deep brain stimulation (DBS) electrode which finds the position of the DBS electrode with respect to a deep brain target region, by using a first volume data set containing information on the deep brain target region and a second volume data set containing information on the DBS electrode implanted toward the deep brain target region, and which includes: a first step of generating a subvolume of the deep brain target region from the first volume data set, and also generating a subvolume of the DBS electrode from the second volume data set; and a second step of overlapping and displaying the subvolume of the deep brain target region and the subvolume of the DBS electrode.

Method of determining the position of a deep brain stimulation electrode

Growing community of inventors

Seoul, South Korea

Sun Ha Paek